Abbott, announced that its ARCHITECT STAT High Sensitivity Troponin─I blood test has received clearance from the US Food and Drug Administration (FDA). As one of the most researched troponin diagnostic
Abbott, announced that its ARCHITECT STAT High Sensitivity Troponin─I blood test has received clearance from the US Food and Drug Administration (FDA). As one of the most researched troponin diagnostic
Pharmamarketeer richt zich op marketingprofessionals van farmaceuten en andere medisch-gerelateerde organisaties in Nederland en België.
Copyright 2023 © Uitgave van MedHealth Communications BV | Privacy disclaimer
